1. 130 PATIENT-TAILORED OUTPATIENT CHEMOTHERAPY REGIMENS FOR METASTATIC COLORECTAL CANCER. (10th December 2015) Authors: Uckun, F. M.; Morar, S.; Lundell, K.; Eddy, L.; Olson, P.; Larson, J.; Qazi, S. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4 PATIENT-TAILORED OUTPATIENT CHEMOTHERAPY REGIMENS FOR INOPERABLE ADVANCED METASTATIC PANCREAS CANCER. (1st January 2005) Authors: Uckun, F. M.; Morar, S.; Olson, P.; Larson, J.; Eddy, L.; Qazi, S. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Conduct, Oversight, and Ethical Considerations of Clinical Trials in Companion Animals with Cancer: Report of a Workshop on Best Practice Recommendations. (7th March 2016) Authors: Page, R.; Baneux, P.; Vail, D.; Duda, L.; Olson, P.; Anestidou, L.; Dybdal, N.; Golab, G.; Shelton, W.; Salgaller, M.; Hardy, C. Journal: Journal of veterinary internal medicine Issue: Volume 30:Number 2(2016:Mar./Apr.) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Experiments on the fragmentation of a buoyant liquid volume in another liquid. (16th May 2014) Authors: Landeau, M.; Deguen, R.; Olson, P. Journal: Journal of fluid mechanics Issue: Volume 749(2014:Jun.) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Experiments on the fragmentation of a buoyant liquid volume in another liquid. (25th June 2014) Authors: Landeau, M.; Deguen, R.; Olson, P. Journal: Journal of fluid mechanics Issue: Volume 749(2014:Jun.) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0343 Blood concentrations of complement split product ic3b and serum c3 associate with sle disease activity. (12th June 2018) Authors: Kim, A.H.; Strand, V.; Sen, D.; Fu, Q.; Mathis, N.; Schmidt, M.; Bruchas, R.; Staten, N.; Olson, P.; Stiening, C.; Atkinson, J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Advanced/ Metastatic Non–Small-Cell Lung Cancer (NSCLC) Harboring KRAS G12C Mutation. (October 2020) Authors: Jänne, P.A.; Rybkin, I.I.; Spira, A.I.; Riely, G.J.; Papadopoulos, K.P.; Sabari, J.K.; Johnson, M.L.; Heist, R.S.; Bazhenova, L.; Barve, M.; Pacheco, J.M.; Leal, T.A.; Velastegui, K.; Cornelius, C.; Olson, P.; Christensen, J.G.; Kheoh, T.; Chao, R.C.; Ou, S.H.I. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Optimal sunscreen use allows vitamin D synthesis. (1st November 2019) Authors: Young, A.R.; Narbutt, J.; Harrison, G.I.; Lawrence, K.P.; Bell, M.; O'Connor, C.; Olson, P.; Grys, K.; Baczynska, K.A.; Rogowski‐Tylman, M.; Wulf, H.C.; Lesiak, A.; Philipsen, P.A. Journal: British journal of dermatology Issue: Volume 181:Number 5(2019) Page Start: e124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0429 Circulating Levels of IC3B and C3 Levels Correlate with Sledai-2K Responder Index-50 (S2K RI-50) Disease Activity Scores – the Castle (Complement Activation Signatures in Systemic Lupus Erythematosus) Study. (9th June 2015) Authors: Kim, A.H.; Strand, V.; Mathis, N.; Fairweather, W.R.; Sen, D.P.; Sinclair, K.C.; Miner, J.J.; Schramm, E.C.; Bruchas, R.R.; Staten, N.; Olson, P.; Stiening, C.M.; Atkinson, J.P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Targeting Krasg12c‐mutant cancer with a mutation‐specific inhibitor. (7th April 2020) Authors: Christensen, J. G.; Olson, P.; Briere, T.; Wiel, C.; Bergo, M. O. Journal: Journal of internal medicine Issue: Volume 288:Number 2(2020) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗